Title 6
Commercial Law — General Regulatory Provisions

CHAPTER 63
Genetic Information Privacy Act

R.I. Gen. Laws § 6-63-6

§ 6-63-6. Exclusions.

(a) This chapter shall not apply to any of the following:

(1) Medical information governed by chapter 37.3 of title 5 (“confidentiality of medical information act”) or to protected health information that is collected, maintained, used, or disclosed by a covered entity or business associate governed by the privacy, security, and breach notification rules issued by the United States Department of Health and Human Services, 45 CFR Parts 160 and 164 of the Code of Federal Regulations established pursuant to the federal Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and the federal Health Information Technology for Economic and Clinical Health Act (Pub. L. No. 111-5);

(2) A provider of health care governed by chapter 37.3 of title 5, or a covered entity governed by the privacy, security, and breach notification rules issued by the United States Department of Health and Human Services, 45 CFR Parts 160 and 164 of the Code of Federal Regulations, established pursuant to the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and the federal Health Information Technology for Economic and Clinical Health Act, Title XIII of the federal American Recovery and Reinvestment Act of 2009 (Pub. L. No. 111-5), to the extent that the provider or covered entity maintains, uses, and discloses genetic information in the same manner as medical information or protected health information, as described in subsection (a)(1) of this section;

(3) A business associate of a covered entity governed by the privacy, security, and data breach notification rules issued by the United States Department of Health and Human Services, 45 CFR Parts 160 and 164 of the Code of Federal Regulations, established pursuant to the federal Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and the federal Health Information Technology for Economic and Clinical Health Act, Title XIII of the federal American Recovery and Reinvestment Act of 2009 (Pub. L. No. 111-5), to the extent that the business associate maintains, uses, and discloses genetic information in the same manner as medical information or protected health information, as described in subsection (a)(1) of this section;

(4) Scientific research or educational activities conducted by a public or private nonprofit postsecondary educational institution that holds an assurance with the United States Department of Health and Human Services pursuant to 45 CFR Part 46 of the Code of Federal Regulations, to the extent that the scientific research and educational activities conducted by that institution comply with all applicable federal and state laws and regulations for the protection of human subjects in research including, but not limited to, the Common Rule pursuant to 45 CFR Part 46 of the Code of Federal Regulations, United States Food and Drug Administration regulations pursuant to 21 CFR Parts 50 and 56 of the Code of Federal Regulations, the federal Family Educational Rights and Privacy Rights Act (20 U.S.C. § 1232g);

(5) The provisions of the newborn screening program pursuant to § 23-13-14;

(6) Tests conducted exclusively to diagnose whether an individual has a specific disease, to the extent that all persons involved in the conduct of the test maintain, use, and disclose genetic information in the same manner as medical information or protected health information, as described in subsection (a)(1) of this section; and

(7) Genetic data used or maintained by an employer, or disclosed by an employee to an employer, to the extent that the use, maintenance, or disclosure of that data is necessary to comply with a local, state, or federal workplace health and safety ordinance, law, or regulation.

(b) Nothing in this chapter shall be construed to affect access to information made available to the public by the consumer.

History of Section.
P.L. 2026, ch. 222, § 2, effective June 19, 2026; P.L. 2026, ch. 223, § 2, effective June 19, 2026.